Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shima Mimura

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Oncology Letters|February 22, 2021
Association between microRNA-527 and glypican-3 in hepatocellular carcinomaKei Nomura, Akira Kitanaka, Hisakazu Iwama, et al.
Diagnostics (Basel, Switzerland)|May 1, 2025
A Noninvasive Method of Diagnosing Metabolic Dysfunction-Associated Steatohepatitis Using Cytokeratin-18 Fragment and FIB-3 IndexTomoko Tadokoro, Miwa Kawanaka, Hirokazu Takahashi, et al.
Cancers|June 28, 2023
Relationship between Accurate Diagnosis of Sarcopenia and Prognosis in Patients with Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab Combination TherapyKyoko Oura, Asahiro Morishita, Takushi Manabe, et al.
International Journal of Molecular Medicine|September 8, 2016
Metformin-suppressed differentiation of human visceral preadipocytes: Involvement of microRNAsKoji Fujita, Hisakazu Iwama, Kyoko Oura, et al.
Anticancer Research|February 27, 2022
Characterization of Cisplatin Effects in Lenvatinib-resistant Hepatocellular Carcinoma CellsSae Hamaya, Shintaro Fujihara, Hisakazu Iwama, et al.
International Journal of Molecular Medicine|August 15, 2014
Profile of microRNAs associated with aging in rat liverShima Mimura, Hisakazu Iwama, Kiyohito Kato, et al.
Cancers|June 2, 2021
Long-Term Outcomes and Evaluation of Hepatocellular Carcinoma Recurrence after Hepatitis C Virus Eradication by Direct-Acting Antiviral Treatment: All Kagawa Liver Disease Group (AKLDG) StudyJoji Tani, Tomonori Senoh, Akio Moriya, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|January 7, 2020
Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinomaAsahiro Morishita, Koji Fujita, Hisakazu Iwama, et al.
Clinical Journal of Gastroenterology|October 17, 2020
A case report of granulocyte colony-stimulating factor-producing hepatocellular carcinoma that recurred after long-term complete responseTakako Nomura, Asahiro Morishita, Joji Tani, et al.
Journal of Gastroenterology and Hepatology|August 26, 2020
Identification of microRNA associated with the elimination of hepatitis C virus genotype 1b by direct-acting antiviral therapiesHirohito Yoneyama, Asahiro Morishita, Hisakazu Iwama, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Oncology Letters|February 22, 2021
Association between microRNA-527 and glypican-3 in hepatocellular carcinomaKei Nomura, Akira Kitanaka, Hisakazu Iwama, et al.
Diagnostics (Basel, Switzerland)|May 1, 2025
A Noninvasive Method of Diagnosing Metabolic Dysfunction-Associated Steatohepatitis Using Cytokeratin-18 Fragment and FIB-3 IndexTomoko Tadokoro, Miwa Kawanaka, Hirokazu Takahashi, et al.
Cancers|June 28, 2023
Relationship between Accurate Diagnosis of Sarcopenia and Prognosis in Patients with Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab Combination TherapyKyoko Oura, Asahiro Morishita, Takushi Manabe, et al.
International Journal of Molecular Medicine|September 8, 2016
Metformin-suppressed differentiation of human visceral preadipocytes: Involvement of microRNAsKoji Fujita, Hisakazu Iwama, Kyoko Oura, et al.
Anticancer Research|February 27, 2022
Characterization of Cisplatin Effects in Lenvatinib-resistant Hepatocellular Carcinoma CellsSae Hamaya, Shintaro Fujihara, Hisakazu Iwama, et al.
International Journal of Molecular Medicine|August 15, 2014
Profile of microRNAs associated with aging in rat liverShima Mimura, Hisakazu Iwama, Kiyohito Kato, et al.
Cancers|June 2, 2021
Long-Term Outcomes and Evaluation of Hepatocellular Carcinoma Recurrence after Hepatitis C Virus Eradication by Direct-Acting Antiviral Treatment: All Kagawa Liver Disease Group (AKLDG) StudyJoji Tani, Tomonori Senoh, Akio Moriya, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|January 7, 2020
Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinomaAsahiro Morishita, Koji Fujita, Hisakazu Iwama, et al.
Clinical Journal of Gastroenterology|October 17, 2020
A case report of granulocyte colony-stimulating factor-producing hepatocellular carcinoma that recurred after long-term complete responseTakako Nomura, Asahiro Morishita, Joji Tani, et al.
Journal of Gastroenterology and Hepatology|August 26, 2020
Identification of microRNA associated with the elimination of hepatitis C virus genotype 1b by direct-acting antiviral therapiesHirohito Yoneyama, Asahiro Morishita, Hisakazu Iwama, et al.
Pageof 6